Cite

HARVARD Citation

    Wanquet, A. et al. (n.d.). Azacitidine treatment for patients with myelodysplastic syndrome and acute myeloid leukemia with chromosome 3q abnormalities. American journal of hematology. 90 (10), pp. 859-863. [Online]. 
  
Back to record